Home
 Contact Us
 
Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter
 
Apredica: Early ADME Tox / ADMET Contract Research

About Apredica

Apredica is the oldest early-ADME/Tox contract research lab in New England. On August 4, 2010 Apredica acquired the High Content Toxicology intellectual property and other assets from Cellumen. On August 6, 2010 Apredica was acquired by the UK-based ADME Tox contract research organization Cyprotex.

Our mission is to provide the benefits of outsourced early ADME/Tox analysis with the same speed and service quality provided by an in-house service department. We combine the flexibility, expertise, and low cost of outsourcing with the speed and scientist-to-scientist communications of insourcing.

Apredica founders are Katherine Tsaioun and Doug Bates.

Our Name

Apredica is pronounced a like "america" (ah-PRED-ik-ah). It is derived from ADME predictive assays.

Our Facilities

Apredica is located in a 4,400 square foot facility at 313 Pleasant St., Watertown, MA. Directions.










Our Equipment

  • Agilent 6410 Triple Quadrupole LC/MS
  • Applied Biosystems API 2000 Triple Quadrupole LC/MS

Our Staff

Each member of Apredica's scientific team has more than 10 years' drug-discovery experience. 80% of our scientific staff have Ph.D.s. Meet our team.

Memberships

Member, Massachusetts Biotechnology Council



Member, Pharma Launcher Consortium


Legal

Apredica is a Delaware incorporated LLC. Please email corporate@apredica.com regarding any legal matter.